bf/NYSE:WST_icon.jpeg

NYSE:WST

West Pharmaceutical Services, Inc.

  • Stock

USD

Last Close

354.11

17/05 20:00

Market Cap

26.74B

Beta: 1.09

Volume Today

425.53K

Avg: 536.93K

PE Ratio

52.81

PFCF: 70.04

Dividend Yield

0.20%

Payout:10.06%

Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
average inventory
169.55M
-
179.20M
5.69%
181.30M
1.17%
190.20M
4.91%
207.25M
8.96%
214.85M
3.67%
225.10M
4.77%
278.50M
23.72%
349.85M
25.62%
396.60M
13.36%
424.75M
7.10%
average payables
105.45M
-
105.55M
0.09%
111.45M
5.59%
120.90M
8.48%
130.05M
7.57%
134.25M
3.23%
143.60M
6.96%
184.95M
28.80%
222.65M
20.38%
223.80M
0.52%
228.90M
2.28%
average receivables
180.35M
-
182.35M
1.11%
180.20M
1.18%
190.95M
5.97%
226.85M
18.80%
270.70M
19.33%
303.75M
12.21%
352.30M
15.98%
437.15M
24.08%
498.20M
13.97%
509.70M
2.31%
book value per share
13.02
-
13.50
3.64%
14.22
5.37%
15.25
7.21%
17.32
13.60%
18.89
9.09%
21.26
12.52%
25.09
18.04%
31.39
25.09%
36.09
14.97%
38.26
6.02%
capex per share
-2.24
-
-1.58
29.37%
-1.83
15.60%
-2.32
27.04%
-1.77
23.77%
-1.42
19.95%
-1.71
20.56%
-2.36
38.16%
-3.41
44.32%
-3.83
12.31%
-4.81
25.68%
capex to depreciation
-1.83
-
-1.25
31.89%
-1.46
17.53%
-1.88
28.19%
-1.35
27.92%
-1.00
25.86%
-1.22
21.89%
-1.60
30.77%
-2.07
29.62%
-2.36
13.90%
-2.64
11.73%
capex to operating cash flow
-0.71
-
-0.61
13.26%
-0.62
1.09%
-0.78
25.20%
-0.50
35.96%
-0.36
26.97%
-0.34
5.12%
-0.37
7.23%
-0.43
17.56%
-0.39
9.41%
-0.47
18.60%
capex to revenue
-0.11
-
-0.08
30.73%
-0.09
19.21%
-0.11
19.96%
-0.08
27.47%
-0.06
25.47%
-0.07
12.69%
-0.08
18.24%
-0.09
10.16%
-0.10
10.16%
-0.12
24.48%
cash per share
3.41
-
3.60
5.52%
3.81
5.92%
2.77
27.39%
3.19
15.26%
4.57
43.03%
5.93
29.97%
8.33
40.36%
10.25
23.07%
12.02
17.27%
11.34
5.66%
days of inventory on hand
69.15
-
68.04
1.60%
70.02
2.91%
72.17
3.06%
72.29
0.18%
66.80
7.60%
69.71
4.35%
85.04
21.99%
83.41
1.91%
86.48
3.68%
87.15
0.77%
days payables outstanding
42.22
-
38.65
8.45%
46.32
19.84%
44.18
4.63%
46.39
5.02%
40.61
12.46%
46.37
14.19%
56.40
21.63%
51.19
9.25%
44.91
12.26%
48.60
8.21%
days sales outstanding
49.53
-
45.97
7.20%
47.30
2.90%
48.49
2.52%
57.79
19.18%
61.25
5.98%
63.34
3.41%
65.51
3.41%
63.03
3.77%
64.15
1.78%
63.35
1.25%
debt to assets
0.22
-
0.20
9.81%
0.18
12.70%
0.13
24.30%
0.16
20.74%
0.12
23.41%
0.14
14.21%
0.12
17.11%
0.10
15.80%
0.09
10.46%
0.08
8.20%
debt to equity
0.41
-
0.35
14.61%
0.29
17.23%
0.20
29.76%
0.23
14.39%
0.14
39.98%
0.21
49.04%
0.18
16.10%
0.14
20.69%
0.12
15.00%
0.11
9.42%
dividend yield
0.01
-
0.01
1.78%
0.01
3.07%
0.01
22.95%
0.01
6.86%
0.01
8.38%
0.00
30.24%
0.00
43.33%
0.00
36.26%
0.00
110.98%
0.00
30.42%
earnings yield
0.03
-
0.03
2.38%
0.02
34.52%
0.02
4.74%
0.02
10.51%
0.03
38.19%
0.02
23.92%
0.02
23.89%
0.02
14.70%
0.03
76.43%
0.02
33.12%
enterprise value
3.56B
-
3.86B
8.38%
4.36B
13.05%
6.24B
43.22%
7.25B
16.16%
7.10B
2.06%
11.01B
55.07%
20.65B
87.45%
34.46B
66.89%
16.93B
50.86%
25.97B
53.36%
enterprise value over ebitda
21.91
-
21.19
3.29%
33.90
60.00%
31.73
6.41%
31.69
0.13%
28.76
9.24%
27.54
4.22%
39.92
44.94%
39.23
1.74%
19.81
49.49%
29.66
49.67%
ev to operating cash flow
16.14
-
21.08
30.66%
20.52
2.65%
28.46
38.65%
27.55
3.20%
24.61
10.65%
30.00
21.87%
43.70
45.67%
59.00
35.02%
23.39
60.36%
33.44
42.99%
ev to sales
2.60
-
2.71
4.34%
3.11
14.80%
4.14
32.85%
4.54
9.63%
4.14
8.81%
5.99
44.74%
9.62
60.64%
12.17
26.53%
5.87
51.80%
8.80
50.09%
free cash flow per share
0.93
-
1.00
7.42%
1.12
12.38%
0.67
40.19%
1.79
167.12%
2.49
38.79%
3.25
30.76%
4.03
23.96%
4.44
10.16%
5.91
32.91%
5.50
6.79%
free cash flow yield
0.02
-
0.02
1.01%
0.02
0.65%
0.01
57.54%
0.02
129.65%
0.03
39.70%
0.02
14.73%
0.01
34.22%
0.01
33.46%
0.03
164.87%
0.02
37.70%
graham net net
-4.31
-
2.03
146.99%
2.82
39.21%
3.06
8.59%
4.55
48.68%
6.29
38.14%
0.38
93.93%
1.70
346.40%
4.57
168.52%
7.40
61.80%
6.73
9.02%
graham number
21.74
-
23.33
7.30%
20.61
11.66%
25.92
25.77%
28.19
8.74%
34.50
22.38%
39.53
14.57%
51.43
30.12%
79.26
54.11%
79.96
0.89%
82.36
3.00%
income quality
1.96
-
1.44
26.71%
2.22
54.39%
1.53
31.23%
1.75
14.36%
1.39
20.16%
1.52
8.92%
1.36
10.16%
0.88
35.34%
1.24
40.03%
1.31
5.90%
intangibles to total assets
0.10
-
0.09
7.28%
0.08
6.93%
0.07
12.30%
0.07
5.58%
0.08
14.09%
0.06
25.85%
0.05
13.76%
0.04
20.87%
0.03
13.34%
0.03
7.13%
interest coverage
10.75
-
14
30.17%
10.29
26.51%
28.11
173.27%
35.22
25.26%
38.14
8.31%
63.11
65.45%
59.84
5.18%
104.49
74.61%
92.91
11.08%
75.11
19.16%
interest debt per share
5.58
-
4.93
11.66%
4.32
12.51%
3.21
25.52%
4.14
28.83%
2.74
33.86%
4.51
64.80%
4.50
0.31%
4.47
0.67%
4.38
2.02%
4.22
3.56%
inventory turnover
5.28
-
5.36
1.63%
5.21
2.83%
5.06
2.97%
5.05
0.18%
5.46
8.22%
5.24
4.16%
4.29
18.03%
4.38
1.95%
4.22
3.55%
4.19
0.77%
invested capital
0.41
-
0.35
14.61%
0.29
17.23%
0.20
29.76%
0.23
14.39%
0.14
39.98%
0.21
49.04%
0.18
16.10%
0.14
20.69%
0.12
15.00%
0.11
9.42%
market cap
3.41B
-
3.77B
10.55%
4.34B
14.87%
6.22B
43.41%
7.29B
17.27%
7.24B
0.65%
11.12B
53.56%
20.94B
88.20%
34.89B
66.67%
17.51B
49.82%
26.51B
51.43%
net current asset value
-114.50M
-
322.60M
381.75%
375.50M
16.40%
413.30M
10.07%
546.50M
32.23%
698.30M
27.78%
290.50M
58.40%
434.40M
49.54%
763.60M
75.78%
987.60M
29.33%
987.90M
0.03%
net debt to ebitda
0.88
-
0.45
49.38%
0.18
58.97%
0.13
29.12%
-0.17
230.64%
-0.57
236.62%
-0.27
52.00%
-0.56
104.07%
-0.50
11.15%
-0.67
35.48%
-0.62
7.74%
net income per share
1.61
-
1.79
11.10%
1.33
25.93%
1.96
47.55%
2.04
4.09%
2.80
37.29%
3.27
16.66%
4.68
43.43%
8.90
89.88%
7.88
11.47%
7.88
0.07%
operating cash flow per share
3.17
-
2.58
18.57%
2.95
14.35%
2.99
1.46%
3.56
19.03%
3.91
9.61%
4.96
27.06%
6.39
28.85%
7.85
22.77%
9.73
23.97%
10.31
5.97%
payables turnover
8.65
-
9.44
9.23%
7.88
16.56%
8.26
4.85%
7.87
4.78%
8.99
14.24%
7.87
12.42%
6.47
17.78%
7.13
10.19%
8.13
13.98%
7.51
7.59%
receivables turnover
7.37
-
7.94
7.76%
7.72
2.82%
7.53
2.46%
6.32
16.09%
5.96
5.64%
5.76
3.30%
5.57
3.30%
5.79
3.92%
5.69
1.74%
5.76
1.26%
research and ddevelopement to revenue
0.03
-
0.03
5.25%
0.02
7.17%
0.02
0.10%
0.02
0.27%
0.02
4.03%
0.02
9.90%
0.02
3.33%
0.02
14.64%
0.02
8.67%
0.02
14.43%
return on tangible assets
0.07
-
0.08
12.35%
0.06
26.36%
0.09
46.67%
0.09
3.71%
0.14
62.31%
0.11
22.28%
0.13
19.02%
0.21
59.39%
0.17
19.34%
0.16
4.59%
revenue per share
19.66
-
20.05
1.97%
19.44
3.02%
20.59
5.90%
21.64
5.10%
23.24
7.40%
24.86
6.99%
29.05
16.84%
38.06
31.01%
38.80
1.95%
39.17
0.96%
roe
0.12
-
0.13
7.21%
0.09
29.71%
0.13
37.63%
0.12
8.37%
0.15
25.85%
0.15
3.68%
0.19
21.51%
0.28
51.80%
0.22
22.99%
0.21
5.61%
roic
0.09
-
0.10
9.97%
0.08
25.80%
0.10
38.63%
0.09
11.59%
0.12
35.51%
0.12
4.09%
0.15
23.60%
0.24
59.23%
0.20
16.87%
0.17
13.63%
sales general and administrative to revenue
0.17
-
0.16
6.27%
0.17
3.45%
0.16
4.54%
0.15
4.53%
0.15
0.90%
shareholders equity per share
13.02
-
13.50
3.64%
14.22
5.37%
15.25
7.21%
17.32
13.60%
18.89
9.09%
21.26
12.52%
25.09
18.04%
31.39
25.09%
36.09
14.97%
38.26
6.02%
stock based compensation to revenue
0.02
-
0.01
15.54%
0.02
61.60%
0.01
38.89%
0.01
22.08%
0.01
12.67%
0.01
50.83%
0.02
19.42%
0.01
16.38%
0.01
38.01%
0.01
3.78%
tangible asset value
743.90M
-
1.18B
59.11%
1.25B
6.01%
1.36B
8.54%
1.54B
12.82%
1.27B
17.33%
1.44B
13.03%
1.71B
19.32%
2.20B
28.58%
2.56B
16.20%
2.76B
7.74%
tangible book value per share
10.69
-
16.69
56.19%
17.43
4.39%
18.58
6.61%
20.79
11.91%
17.19
17.33%
19.40
12.88%
23.18
19.48%
29.60
27.72%
34.40
16.20%
36.62
6.46%
working capital
413.80M
-
406.80M
1.69%
359.40M
11.65%
400.90M
11.55%
464M
15.74%
610.70M
31.62%
717.10M
17.42%
870.30M
21.36%
1.15B
31.90%
1.40B
22.01%
1.26B
9.70%

All numbers in USD (except ratios and percentages)